Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

The global oncology market is projected to nearly triple from $279.98 billion in 2026 to an estimated $748.17 billion by 2035 ...

Researchers are shining a light on cancer cells' energy centers – literally – to damage these power sources and trigger widespread cancer cell death. In a new study, scientists combined strategies to ...

For some subtypes of non-Hodgkin lymphoma, you may get a targeted therapy. This is more exact than standard chemotherapy, which affects all fast-growing cells in the body. Small molecule inhibitors ...

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

Targeted protein degradation (TPD) therapy is a promising new class of targeted treatments. Based on a cell’s natural mechanism for eliminating diseased proteins, this therapy can combat hard-to-treat ...

Modern medicine is more advanced than ever, yet clinical care still leans heavily on what is, in practice, informed guesswork. Doctors make the most probable diagnosis, select the therapy most likely ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, /CNW/ — Equity-Insider.com News Commentary — The five-year cancer survival rate in the United States has reached a record 70% ...

IgA nephropathy (IgAN), or Bergers disease, is a kidney condition that occurs when abnormal immunoglobulin A (IgA) antibodies trigger inflammation in the kidneys.Until recently, treatment for IgAN ...